Tectonic Therapeutic Inc. (TECX)
NASDAQ: TECX
· Real-Time Price · USD
19.80
-0.27 (-1.32%)
At close: Jun 27, 2025, 3:59 PM
19.80
0.00%
After-hours: Jun 27, 2025, 04:34 PM EDT
-1.32% (1D)
| Bid | 19 |
| Market Cap | 369.72M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -58.67M |
| EPS (ttm) | -3.14 |
| PE Ratio (ttm) | -6.31 |
| Forward PE | -4.32 |
| Analyst | Buy |
| Ask | 22 |
| Volume | 244,620 |
| Avg. Volume (20D) | 196,120 |
| Open | 20.05 |
| Previous Close | 20.07 |
| Day's Range | 19.25 - 20.57 |
| 52-Week Range | 13.70 - 61.07 |
| Beta | 1.49 |
About TECX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TECX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TECX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+11.53%
Tectonic Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
4 months ago
+113.22%
Tectonic Therapeutic shares are trading higher after interim results showed TX45 achieved improvements in hemodynamics that met and exceeded prespecified objectives.
2 months ago · seekingalpha.com
Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEFWe initiate a Buy rating on Tectonic Therapeutic due to promising data for TX45. TX45 showed positive interim Phase 1b results, but the APEX Phase 2 trial with 180 patients will be crucial for validat...